IBB vs IVV: Holdings Overlap
iShares · 254 holdings · $9.3B · as of 2026-03-31
iShares · 503 holdings · $901.0B · as of 2026-03-31
How similar are IBB and IVV?
iShares Biotechnology ETF (IBB, by iShares) holds 254 positions; iShares Core S&P 500 ETF (IVV, by iShares) holds 503. They have 9 holdings in common, and by portfolio weight the two funds are 1.1% identical. In practical terms the pair is essentially distinct, holding almost none of the same securities.
- Overlap by Weight
- 1.1%Sum of the smaller weight of each shared holding
- Shared Holdings
- 9IBB holds 254 · IVV holds 503
- Weight in Shared Holdings
- IBB 37%·IVV 1%Share of each fund's weight in stocks both funds own
Based on each fund's latest official holdings. How is this calculated?
What makes each fund different
Only in IBB
245 of 254 positions (62.6% of the fund) are not held by IVV. Showing the top 30 by weight.
Sector Breakdown
| Sector | IBB | IVV |
|---|---|---|
| Health Care | 91.0% | 9.4% |
| Information Technology | 0.0% | 32.6% |
| Financials | 0.0% | 12.6% |
| Communication Services | 0.0% | 10.5% |
| Consumer Discretionary | 0.0% | 9.8% |
| Other Sectors | 0.0% | 24.8% |
| Unclassified | 8.9% | 0.0% |
Share of each fund's portfolio weight by GICS-style sector, compiled from issuer fund data and our own classification of the holdings, not the issuers' published sector charts. “Unclassified” is weight we could not classify (9% of IBB, 0% of IVV).
Performance
| Fund | 1M | YTD | 1Y | 3Y (ann.) | 5Y (ann.) | 10Y (ann.) | Yield |
|---|---|---|---|---|---|---|---|
| IBB | -0.3% | +17.3% | +51.0% | +16.4% | +3.1% | +7.4% | 0.21% |
| IVV | +3.4% | +14.0% | +23.7% | +21.3% | +13.4% | +15.4% | 1.05% |
Total returns including dividends, from adjusted daily closes as of 2026-08-07. 3Y/5Y/10Y are annualized. Yield is trailing-12-month distributions over the last close. Past performance does not predict future results.
Project the growth of $10,000 in IBB vs IVV →
Shared Holdings(9)
The top 9 shared positions account for 100% of the overlap, led by AMGN, GILD and VRTX.
 AMGNAmgen, Inc. | 7.51% | 0.34% | 0.34% |
|---|---|---|---|
 GILDGilead Sciences, Inc. | 7.75% | 0.31% | 0.31% |
 VRTXVertex Pharmaceuticals, Inc. | 7.44% | 0.20% | 0.20% |
 REGNRegeneron Pharmaceuticals, Inc. | 7.21% | 0.14% | 0.14% |
 BIIBBiogen, Inc. | 2.46% | 0.05% | 0.05% |
 MRNAModerna, Inc. | 1.68% | 0.03% | 0.03% |
 INCYIncyte Corp. | 1.70% | 0.03% | 0.03% |
 CRLCharles River Laboratories International, Inc. | 0.77% | 0.02% | 0.02% |
 TECHBio-Techne Corp. | 0.74% | 0.01% | 0.01% |
Frequently Asked Questions
How much do IBB and IVV overlap?
IBB and IVV overlap by 1.1% of portfolio weight. They share 9 holdings (IBB holds 254 positions and IVV holds 503), based on each fund's latest SEC-reported holdings.
Is it redundant to own both IBB and IVV?
The two portfolios are 1.1% identical by weight. Owning both is genuine diversification: the funds hold almost none of the same securities.
What are the biggest shared holdings of IBB and IVV?
The largest positions held by both funds are AMGN, GILD, VRTX, REGN and BIIB. Together the top 9 shared positions account for 100% of the total overlap.
What does IBB own that IVV doesn't?
245 positions (62.6% of IBB) are unique to IBB, led by ALNY, INSM and ARGX. In the other direction, 494 positions (98.7% of IVV) are unique to IVV.